The store will not work correctly when cookies are disabled.
3-(4-Methoxyphenyl)-5-(2,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102944
PubChem CID: 72792756
Max Phase: Preclinical
Molecular Formula: C22H20N2O3
Molecular Weight: 360.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2c[nH]c3ncc(-c4ccc(OC)cc4OC)cc23)cc1
Standard InChI: InChI=1S/C22H20N2O3/c1-25-16-6-4-14(5-7-16)20-13-24-22-19(20)10-15(12-23-22)18-9-8-17(26-2)11-21(18)27-3/h4-13H,1-3H3,(H,23,24)
Standard InChI Key: KFDRCCYTVOCUEC-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
14.0400 -21.2371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0389 -22.0645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7536 -22.4773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7519 -20.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3254 -20.8248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4673 -21.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4675 -22.0645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2579 -22.3211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7463 -21.6486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2575 -20.9765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6455 -20.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4707 -20.2243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8590 -19.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4227 -18.7960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5939 -18.8265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2095 -19.5540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3288 -19.9989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6150 -19.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8997 -19.9994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9025 -20.8286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6168 -21.2371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1845 -19.5880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1833 -18.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8100 -18.0677 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6345 -18.0390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6199 -22.0621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9069 -22.4772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
19 22 1 0
22 23 1 0
14 24 1 0
24 25 1 0
21 26 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.41 | Molecular Weight (Monoisotopic): 360.1474 | AlogP: 4.92 | #Rotatable Bonds: 5 |
Polar Surface Area: 56.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.85 | CX LogP: 4.04 | CX LogD: 4.04 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.55 | Np Likeness Score: -0.28 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |